We recently compiled a list of the 7 Most Promising Gene Editing Stocks According to Analysts. Twist Biosciences Corporation is one of the most promising stocks on our list. TheFly reported on December 15 that Barclays raised its price target for TWST from $37 to $39 while maintaining an Overweight rating, reflecting confidence in the company’s margin progress and anticipated performance in the life sciences tools sector. This follows an Overweight initiation on November 3, 2025, by Stephens with a $41 p ...